Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 3/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | GLP1R | P43220 | 8/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | FNTA | P49354 | 2/20 | 0.33 |
| ▸ | FNTB | P49356 | 2/20 | 0.33 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.33 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.33 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18888077 | 0.83 | NMT1 (0.49) | GLP1RNOD1SIRT5 | |
| SCHEMBL16156165 | 0.82 | SIRT6 (0.49) | FNTAFNTBSIRT6SIRT1 | |
| SCHEMBL16638262 | 0.81 | ALDH1A1 (0.44) | ALDH1A1ALBFOLH1LTA4HCYP1A2 | |
| SCHEMBL21242815 | 0.81 | FOLH1 (0.41) | ALDH1A1ALBFOLH1GLP1RNOD1 | |
| SCHEMBL18888118 | 0.80 | NMT1 (0.44) | GLP1RNOD1SIRT5 | |
| SCHEMBL16156095 | 0.79 | NMT1 (0.43) | GLP1RNOD1SIRT5 | |
| SCHEMBL23974073 | 0.77 | LTA4H (0.46) | ALDH1A1ALBFOLH1NOD1LTA4H | |
| SCHEMBL16947953 | 0.76 | FOLH1 (0.48) | ALBFOLH1GLP1RNOD1FNTA | |
| SCHEMBL16947836 | 0.76 | FOLH1 (0.48) | ALBFOLH1GLP1RNOD1FNTA | |
| SCHEMBL27460520 | 0.74 | GLP1R (0.53) | ALBFOLH1GLP1RNOD1FNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150210745-A1 | Double-Acylated GLP-1 Derivatives with a Linker | NOVO NORDISK AS (DK) | 2015-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150210745-A1 | Double-Acylated GLP-1 Derivatives with a Linker | GLP1R, VIP, IAPP | ALDH1A1 3185/4885ALB 2710/4885FOLH1 1941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.